Medicine
Potassium chloride 750 mg extended-release tablet
Potassium chloride 750 mg extended-release tablet is a generic prescription medicine for oral use, made by 30 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), Excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Potassium chloride
- Brand
- Sold under the generic name
- Strength
- 750 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 90 tablets, 1000 tablets and 201 more
- Manufacturers
- Granules IndiaIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaZydus LifesciencesIndiaStrides PharmaIndiaSun Pharmaceutical IndustriesIndiaCamber PharmaceuticalsIndiaUpsher-Smith LaboratoriesAdvagen Pharma30 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), Excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A12BA01 Potassium chloride
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 April 1986
- Identifiers
- RxCUI 1801298, 628953, 403888 +4DailyMed set ID b5505a39-57f1-4ed5-b845-4f1d8aa10950, 3b403d60-4246-d765-e063-6394a90a12e8, 7fd82f08-8ad0-4ee2-8eb6-5c973f98baee +37NDC 71335-2503, 71610-932, 72865-194 +37Application ANDA214452, ANDA211797, ANDA214422 +15
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 30 labelers. The register lists 204 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle | 59651-429-01 | Aurobindo PharmaIndia | 31 March 2021 |
| 90 tablet, extended release in 1 bottle | 59651-429-90 | Aurobindo PharmaIndia | 31 March 2021 |
| 1000 tablet, extended release in 1 bottle | 59651-429-99 | Aurobindo PharmaIndia | 31 March 2021 |
| 100 tablet, film coated, extended release in 1 bottle | 65862-987-01 | Aurobindo PharmaIndia | 19 December 2018 |
| 120 blister pack in 1 carton / 6 tablet, film coated, extended release in 1 blister pack | 65862-987-12 | Aurobindo PharmaIndia | 19 December 2018 |
| 80 blister pack in 1 carton / 4 tablet, film coated, extended release in 1 blister pack | 65862-987-80 | Aurobindo PharmaIndia | 19 December 2018 |
| 1000 tablet, film coated, extended release in 1 bottle | 65862-987-99 | Aurobindo PharmaIndia | 19 December 2018 |
| 100 tablet, extended release in 1 bottle | 70010-022-01 | Granules IndiaIndia | 22 October 2020 |
| 500 tablet, extended release in 1 bottle | 70010-022-05 | Granules IndiaIndia | 22 October 2020 |
| 1000 tablet, extended release in 1 bottle | 70010-022-10 | Granules IndiaIndia | 4 May 2021 |
| 3 blister pack in 1 carton / 10 tablet, extended release in 1 blister pack | 70010-022-61 | Granules IndiaIndia | 3 January 2022 |
| 10 blister pack in 1 carton / 10 tablet, extended release in 1 blister pack | 70010-022-62 | Granules IndiaIndia | 3 January 2022 |
| 100 tablet, extended release in 1 bottle | 70010-136-01 | Granules IndiaIndia | 30 January 2021 |
| 500 tablet, extended release in 1 bottle | 70010-136-05 | Granules IndiaIndia | 30 January 2021 |
| 1000 tablet, extended release in 1 bottle | 70010-136-10 | Granules IndiaIndia | 30 January 2021 |
| 100 tablet, extended release in 1 bottle | 68382-861-01 | Zydus LifesciencesIndia | 3 February 2022 |
| 1000 tablet, extended release in 1 bottle | 68382-861-10 | Zydus LifesciencesIndia | 3 February 2022 |
| 1000 tablet, extended release in 1 bottle | 70771-1599-0 | Zydus LifesciencesIndia | 3 February 2022 |
| 100 tablet, extended release in 1 bottle | 70771-1599-1 | Zydus LifesciencesIndia | 3 February 2022 |
| 100 tablet, extended release in 1 bottle | 31722-133-01 | Camber PharmaceuticalsIndia | 20 January 2021 |
| 500 tablet, extended release in 1 bottle | 31722-133-05 | Camber PharmaceuticalsIndia | 20 January 2021 |
| 100 tablet, film coated, extended release in 1 bottle | 33342-418-11 | Macleods PharmaceuticalsIndia | 8 September 2024 |
| 10 blister pack in 1 carton / 10 tablet, film coated, extended release in 1 blister pack | 33342-418-12 | Macleods PharmaceuticalsIndia | 8 September 2024 |
| 500 tablet, film coated, extended release in 1 bottle | 33342-418-15 | Macleods PharmaceuticalsIndia | 8 September 2024 |
| 10 blister pack in 1 carton / 7 tablet, film coated, extended release in 1 blister pack | 33342-418-34 | Macleods PharmaceuticalsIndia | 8 September 2024 |
| 100 tablet, extended release in 1 bottle | 64380-861-06 | Strides PharmaIndia | 27 November 2018 |
| 500 tablet, extended release in 1 bottle | 64380-861-07 | Strides PharmaIndia | 27 November 2018 |
| 1000 tablet, extended release in 1 bottle | 64380-861-08 | Strides PharmaIndia | 27 November 2018 |
| 100 tablet, extended release in 1 bottle | 63304-076-01 | Sun Pharmaceutical IndustriesIndia | 20 November 2019 |
| 500 tablet, extended release in 1 bottle | 63304-076-05 | Sun Pharmaceutical IndustriesIndia | 20 November 2019 |
| 1000 tablet, extended release in 1 bottle | 63304-076-10 | Sun Pharmaceutical IndustriesIndia | 20 November 2019 |
| 1000 tablet, film coated, extended release in 1 bottle | 0832-5323-10 | Upsher-Smith Laboratories | 21 June 2019 |
| 100 tablet, film coated, extended release in 1 bottle | 0832-5323-11 | Upsher-Smith Laboratories | 21 June 2019 |
| 64000 tablet, extended release in 1 drum | 24979-230-00 | Upsher-Smith Laboratories | 1 June 2025 |
| 100 tablet, extended release in 1 bottle | 24979-230-01 | Upsher-Smith Laboratories | 28 October 2024 |
| 1000 tablet, extended release in 1 bottle | 24979-230-03 | Upsher-Smith Laboratories | 28 October 2024 |
| 100 tablet, extended release in 1 bottle, plastic | 24979-231-01 | Upsher-Smith Laboratories | 10 April 2023 |
| 500 tablet, extended release in 1 bottle, plastic | 24979-231-02 | Upsher-Smith Laboratories | 10 April 2023 |
| 1000 tablet, extended release in 1 bottle, plastic | 24979-231-03 | Upsher-Smith Laboratories | 10 April 2023 |
| 1000 tablet, film coated, extended release in 1 bottle | 72888-075-00 | Advagen Pharma | 25 July 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 April 1975 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Potassium chloride 750 mg extended-release tablet.
Other strengths and forms of Potassium chloride
Clinical summary
Potassium chloride is an osmotic laxative indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. MedsAcross supplies Potassium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Potassium chlorideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KLOR-CON prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Potassium chloride 750 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.